Medicare’s $2,100 Drug Quietly Reshapes Prescription Costs for Investors
Medicare's out-of-pocket cap for covered prescriptions rises to $2,100 in 2026, ending the donut-hole-era for many pa...
Curious about your investment portfolio? Discover what to include to ensure a balanced and profitable mix of assets.
23,656 articlesMedicare's out-of-pocket cap for covered prescriptions rises to $2,100 in 2026, ending the donut-hole-era for many pa...
Amazon stock is drawing renewed investor attention as AI monetization and AWS growth accelerate. A fresh price predic...
Three ETFs have stood out in 2026 by delivering positive returns while the S&P 500 retreats. RSP, NLR, and VXUS are t...
A major energy infrastructure company is funding AI data-center expansion with a generous dividend, while C3.AI conte...
Allium, a crypto analytics startup, secures a $40 million Series B to scale its data platform for institutional clien...
A defensive utility ETF is gaining attention as AI infrastructure ramps up, potentially making this “boring” ETF one ...
As defense budgets stabilize and technology explodes, investors are re-pricing defense names. This piece examines why...
As IPO risk rises in 2026, Altria’s reliable 6% dividend and decades of payout growth position it as a steadier optio...
A leveraged Treasury ETF illustrates how daily rebalancing can crush long-term returns. TMF turned $10,000 into $1,52...
A temporary $6,000 tax deduction for seniors shields many retirees from taxes on Social Security benefits, but the re...
Commercial Metals posted a blowout quarter in Q2 2026, with revenue hitting $2.132 billion and net income of $93 mill...
Public trading disclosures show a sharp spike in activity by the former president, with Trump’s trading volume just s...